EPFL researchers have developed a novel AI-driven model designed to predict protein sequences from backbone scaffolds, incorporating complex molecular environments….

The Campus Biotech-based BioMedTech company announced the closure of a CHF 3.3 Million Seed financing round with private investors. The…

SamanTree Medical, a leading medical technology company specialising in innovative solutions to improve the outcomes of surgery, announced the closing…

Relief Therapeutics, a biopharmaceutical company committed to delivering innovative treatment options for select specialities, unmet and rare diseases, announced the…

In a collaboration with EPFL Lausanne, ETH Zurich and the University of Southern California researchers at the Paul Scherrer Institute…

AC Immune, unveiled a novel class of neurodegenerative disease-fighting drug-candidates called morADC (Morphomer® Antibody Drug Conjugate) in a presentation at…

Navigation, Obstacle, Artificial intelligence (NOA) is the new brand name for biped’s AI mobility vest that can guide blind and…

Oryl Photonics achieved a significant milestone: together with its partners of the FASS – Fast and Accurate Solubility for Sustainability…

By identifying mechanisms unique to leukaemia-causing cells, a French-Swiss team has discovered a new way to fight the disease.  …

Swiss-based start-ups Impli and Yalosys, along with the technology innovation centre CSEM, announce a significant milestone in women’s healthcare—CERES. This…

UNIGE scientists have discovered how yeast cells sense physical stresses on the membranes that protect them.     Cell membranes…

Regenosca closes CHF 1Million pre-seed round to demonstrate endoscopic delivery of TissueSpan implants.     Regenosca creates unique bio-implants, enabling…